Workshop

Advancing Long-Acting Injectables and Immunotherapies through the Tunability of Lactide/Glycolide Polymers

May 5, 2026​ | Cambridge, MA, USA


Overview

Long-acting injectables like microparticles and implants, are among the most complex parenteral products in the pharmaceutical industry. Long acting injectables using bioabsorbable polymers for systemic and local drug delivery have improved the lives of millions of patients globally, based on successful outcomes for the treatment of cancer, schizophrenia, diabetes, substance abuse, as well as ocular, rare and hormonal diseases. These drug products have many advantages including simplification of the drug regimen by decreasing dosing frequency, improving efficacy, treatment adherence, and achieving local drug delivery to areas such as eyes and joints.

In this workshop, Evonik’s drug delivery and polymer experts will share their experiences and insights on the development of long-acting, bioabsorbable injectables, covering the science of cornerstone lactide/glycolide polymers and their use in drug products introduced to the market over the past 40 years. Distinguished guest speakers will present on the microstructure of polymeric formulations and nanoparticles.

Key learnings for participants

  • Brief history and science behind long-acting polymeric injectable drug products on the market, including microparticles and implants
  • Overview of key lactide/glycolide polymer properties and highly specialized polymer grades relevant to drug delivery formulations
  • Recent application trends, including immunotherapies, ocular drug delivery, and future trends
  • Polymeric nanoparticles
  • Custom polymer synthesis and drug development service





Note: Please fill in your details and click 'Submit' to register for the workshop. Once we have received your registration, we will send you a status notification as soon as possible. Due to the high demand for our workshops, we sometimes need to reject registrations or put you on a waiting list. Workshop materials will be available for download at the end of the workshop. Any photographs taken during the event are the property of Evonik and may be used for promotional purposes.



Details
Participation fee: Free of charge 
Workshop language: English



Agenda
The workshop will start at 8:30 a.m. on Tuesday, May 5, 2026, and finish at 3:45 p.m. on the same day. To see the detailed workshop program please click here.



Venue
The workshop will take place at:
238 Main Street(located at Kendall/M.I.T. MBTA stop)
Cambridge, MA 02142
USA

Fill out the form to register for the workshop:

Agenda

08:30 am | Registration & Breakfast

09:00 am | Welcome & Introduction
Tracy Cheavious, Business Development Manager
Evonik Health Care

09:15 am | History and Science of Lactide/Glycolide Polymers
Dr. Tom Tice, Senior Director, Strategic and Technical Marketing
Evonik Health Care

10:00 am | Guest Speaker

10:30 am | Coffee Break & Networking

10:45 am | Long-Acting Formulations – Microparticles and Implants
Dr. Tom Tice, Senior Director, Strategic and Technical Marketing
Evonik Health Care

11:30 am | Choosing the Right RESOMER® & LACTEL® Polymer for Your Formulation
Dr. Manish Rane, Associate Director Technical Sales
Evonik Health Care

12:00 pm | Lunch & Networking

01:00 pm | Microstructure Intelligence to Accelerate Polymeric Product Development
Shawn Zhang, Founder and CEO
DigiM

01:45 pm | Custom Polymer Synthesis for Polymer Tunability
Jay Stone, Director, Technical Marketing
Evonik Health Care

02:30 pm | Coffee Break & Networking

02:45 pm | Small Particles, Big Impact: Polymer Nanoparticles in Engineering Immune Tolerance
Dr. Nataliya Nukolova, Director, Formulation
SOBI

03:15 pm | Medicines of the Future Using RESOMER® & LACTEL® Polymers
Dr. Tom Tice, Senior Director, Strategic and Technical Marketing
Evonik Health Care

03:45 pm | Wrap-up





Disclaimer

Notice for business transactions
We assume that you are not currently or foreseeably involved in a business decision in favour of or in direct connection with the Evonik Group or, if this is the case, the decision will not be influenced by this invitation. Therefore, we do not see any concerns on our part regarding your participation. However, we would like to ask you to ensure that you are allowed to accept the invitation in accordance with the regulations that apply to you.

Note for public officials
We assume that you are not or have not been involved in any official act in favour of or in connection with the Evonik Group, either now or in the foreseeable future or in the past and therefore your participation in the event is not subject to any concerns. In addition, we ask you to ensure that your superior approves your participation or you may also accept the invitation in accordance with the rules applicable to you. By registering or participating, you confirm to us that the acceptance of this invitation is permitted according to your internal rules and that you have obtained all necessary approvals. If this is not the case, we ask you for a corresponding note.

Tax notices
Any tax liability resulting from this event will be borne by Evonik Industries AG through a flat-rate tax levy pursuant to Section 37b of the German Income Tax Act (EStG). If you are not taxable in Germany, please clarify whether you must report the invitation to your employer for taxation or whether taxation must be made via your income tax return.




QUESTIONS? 

Likhitha Bingham
Marketing Analyst
+1 256-783-9347

Cléa Michel

Cléa Michel is product manager for Cell Culture Ingredients at Evonik Health Care. She provides biopharma companies and media manufacturers with the finest specialty ingredients to increase cell culture performance. Cléa has a background in biochemistry and biotechnology engineering and holds a master’s degree from the National Institute of Applied Sciences in Lyon, France. She has held various positions in marketing, project management and business development and is passionate about innovative solutions that enable the successful development of life-saving biopharmaceuticals.
Dr. Stephan Brinkmann

Stephan Brinkmann works as project manager and head of Evonik's Biopharma Applications group at Evonik R&D for the Health Care business line. He is responsible for biopharma innovation projects as well as application tests of Evonik's cell culture ingredients (i.e., cQrex® peptides). Stephan studied molecular biotechnology at Bielefeld University in Germany, where he specialized in biopharma upstream and downstream process development. Before joining Evonik, Stephan worked in Switzerland on industrial mammalian cell line development for the production of therapeutic biologics. Stephan obtained his Ph.D. in a public private partnership with Sanofi and later Evotec at Fraunhofer IME in Giessen with a focus on the discovery of natural products, especially peptides.

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register